DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.11 EUR
+0 (+0.07%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CPR was profitable.
  • CPR had a positive operating cash flow in the past year.
  • In the past 5 years CPR has always been profitable.
  • Each year in the past 5 years CPR had a positive operating cash flow.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • CPR's Return On Assets of 4.27% is fine compared to the rest of the industry. CPR outperforms 66.67% of its industry peers.
  • The Return On Equity of CPR (8.97%) is comparable to the rest of the industry.
  • With a decent Return On Invested Capital value of 6.57%, CPR is doing good in the industry, outperforming 63.33% of the companies in the same industry.
  • CPR had an Average Return On Invested Capital over the past 3 years of 6.98%. This is in line with the industry average of 7.69%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR has a better Profit Margin (11.35%) than 66.67% of its industry peers.
  • CPR's Profit Margin has been stable in the last couple of years.
  • CPR has a Operating Margin of 19.74%. This is in the better half of the industry: CPR outperforms 66.67% of its industry peers.
  • CPR's Operating Margin has improved in the last couple of years.
  • CPR has a better Gross Margin (60.31%) than 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. CPR.MI Health Analysis

2.1 Basic Checks

  • CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CPR has been reduced compared to 1 year ago.
  • The number of shares outstanding for CPR has been increased compared to 5 years ago.
  • CPR has a better debt/assets ratio than last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.63 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.63, CPR is doing good in the industry, outperforming 76.67% of the companies in the same industry.
  • CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
  • The Debt to FCF ratio of CPR (6.60) is better than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
  • CPR has a Debt to Equity ratio of 0.59. This is in the better half of the industry: CPR outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.63
ROIC/WACC1
WACC6.57%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • CPR has a Current Ratio of 2.22. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
  • CPR's Current ratio of 2.22 is fine compared to the rest of the industry. CPR outperforms 80.00% of its industry peers.
  • CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CPR has a Quick ratio of 0.96. This is in the better half of the industry: CPR outperforms 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

5

3. CPR.MI Growth Analysis

3.1 Past

  • CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
  • Looking at the last year, CPR shows a decrease in Revenue. The Revenue has decreased by -0.60% in the last year.
  • The Revenue has been growing by 11.48% on average over the past years. This is quite good.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.72% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.29% on average over the next years.
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

2

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.07 indicates a rather expensive valuation of CPR.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 60.00% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CPR to the average of the S&P500 Index (25.61), we can say CPR is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 18.85, CPR is valued on the expensive side.
  • CPR's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. CPR is around the same levels.
Industry RankSector Rank
PE 21.07
Fwd PE 18.85
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR is on the same level as its industry peers.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CPR.
Industry RankSector Rank
P/FCF 19.37
EV/EBITDA 12.46
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CPR's earnings are expected to grow with 13.95% in the coming years.
PEG (NY)2.93
PEG (5Y)1.75
EPS Next 2Y9.68%
EPS Next 3Y13.95%

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • CPR has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.68, CPR is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.89, CPR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CPR pays out 22.52% of its income as dividend. This is a sustainable payout ratio.
DP22.52%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (3/26/2026, 9:19:09 AM)

6.11

+0 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.32%
Inst Owner ChangeN/A
Ins Owners50.85%
Ins Owner ChangeN/A
Market Cap7.52B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts71.85
Price Target7.1 (16.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE 21.07
Fwd PE 18.85
P/S 2.47
P/FCF 19.37
P/OCF 10.94
P/B 1.95
P/tB 18.96
EV/EBITDA 12.46
EPS(TTM)0.29
EY4.75%
EPS(NY)0.32
Fwd EY5.3%
FCF(TTM)0.32
FCFY5.16%
OCF(TTM)0.56
OCFY9.14%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)2.93
PEG (5Y)1.75
Graham Number4.52
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.63
F-Score8
WACC6.57%
ROIC/WACC1
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year26.5%
EBIT Next 3Y15.07%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


What is the profitability of CPR stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for CPR stock?

The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 7.18% in the next year.